TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
COYA

Coya Therapeutics, Inc.

Healthcare · Biotechnology

5.10$ -1.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Coya Therapeutics, Inc. (COYA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 47,308 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet COYA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
12 41 37 40 36 44 38 33 32 50 53 47,308
12 41 37 40 36 44 38 33 32 50 53 47,058
11 33 36 37 31 38 36 30 28 47 51 43,181
11 33 36 37 31 38 36 30 28 47 51 43,181
– 7.5 – – – 0.7 0.7 – – – – –
1.8 5.6 5.0 4.7 3.5 4.8 5.0 5.1 4.8 6.9 4.3 4,032
1.8 5.1 4.3 3.8 2.3 3.8 4.3 4.5 3.7 5.9 3.5 3,512
– 0.7 0.7 – – – – – – – – –
0.6 1.2 1.6 1.9 0.3 1.6 1.7 0.9 1.1 1.1 0.9 1,086
10 36 32 35 32 40 33 28 27 43 49 43,276
-27 -26 -31 -34 -38 -41 -48 -54 -56 -62 -69 -75,809
9.9 10 14 15 15 16 17 17 17 17 23 23

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?